dQM CMS Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2026.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-cms-2026/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Strong CYP3A4 Inhibitor Medications - XML Representation

Draft as of 2026-06-16

Raw xml | Download

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="strong-cyp3a4-inhibitors"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet strong-cyp3a4-inhibitors</b></p><a name="strong-cyp3a4-inhibitors"> </a><a name="hcstrong-cyp3a4-inhibitors"> </a><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><span title="Version is not explicitly stated. No matching Code System found"> version Not Stated (use latest from terminology server)</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>308460</td><td>Clarithromycin 500 MG Oral Tablet</td></tr><tr><td>200344</td><td>Itraconazole 100 MG Oral Capsule</td></tr><tr><td>349251</td><td>Ketoconazole 200 MG Oral Tablet</td></tr><tr><td>349439</td><td>Ritonavir 100 MG Oral Tablet</td></tr><tr><td>349478</td><td>Indinavir 400 MG Oral Capsule</td></tr><tr><td>349476</td><td>Saquinavir 200 MG Oral Capsule</td></tr><tr><td>359906</td><td>Nelfinavir 250 MG Oral Tablet</td></tr></table></li></ul></div>
  </text>
  <url value="https://example.org/fhir/ValueSet/strong-cyp3a4-inhibitors"/>
  <version value="1.0.0"/>
  <name value="StrongCYP3A4Inhibitors"/>
  <title value="Strong CYP3A4 Inhibitor Medications"/>
  <status value="draft"/>
  <date value="2026-06-16T17:19:32+00:00"/>
  <description
               value="RxNorm codes for strong CYP3A4 inhibitors that may interact with atorvastatin, including clarithromycin, HIV protease inhibitors, and itraconazole"/>
  <compose>
    <include>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <concept>
        <code value="308460"/>
        <display value="Clarithromycin 500 MG Oral Tablet"/>
      </concept>
      <concept>
        <code value="200344"/>
        <display value="Itraconazole 100 MG Oral Capsule"/>
      </concept>
      <concept>
        <code value="349251"/>
        <display value="Ketoconazole 200 MG Oral Tablet"/>
      </concept>
      <concept>
        <code value="349439"/>
        <display value="Ritonavir 100 MG Oral Tablet"/>
      </concept>
      <concept>
        <code value="349478"/>
        <display value="Indinavir 400 MG Oral Capsule"/>
      </concept>
      <concept>
        <code value="349476"/>
        <display value="Saquinavir 200 MG Oral Capsule"/>
      </concept>
      <concept>
        <code value="359906"/>
        <display value="Nelfinavir 250 MG Oral Tablet"/>
      </concept>
    </include>
  </compose>
</ValueSet>